Literature DB >> 34630768

Blue Rubber Bleb Nevus Syndrome Complicated by Enhanced-Fibrinolytic-Type DIC: A Case Report.

Shinya Yamada1, Masahisa Arahata1, Eriko Morishita1, Hidesaku Asakura1.   

Abstract

A 54-year-old Japanese man was diagnosed with blue rubber bleb nevus syndrome (BRBNS) due to venodilation in the lower extremities at birth and gastrointestinal vascular malformations. He also had small bowel bleeding and enhanced-fibrinolytic-type disseminated intravascular coagulation (DIC). Endoscopic sclerotherapy for intestinal hemangioma could not be performed because of bleeding concerns; instead, a combined anticoagulant and antifibrinolytic treatment was performed. Although combination treatment with unfractionated heparin and tranexamic acid proved ineffective for small bowel bleeding, combination treatment with apixaban and tranexamic acid dramatically improved enhanced-fibrinolytic-type DIC. In BRBNS, treatment strategies should be considered after performing detailed coagulation tests.
© 2021 The Editorial Committee of Annals of Vascular Diseases.

Entities:  

Keywords:  blue rubber bleb nevus syndrome; disseminated intravascular coagulation; fibrinolytic activation

Year:  2021        PMID: 34630768      PMCID: PMC8474085          DOI: 10.3400/avd.cr.20-00148

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  7 in total

1.  Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro.

Authors:  Xiaosui Jiang; Earl J Crain; Joseph M Luettgen; William A Schumacher; Pancras C Wong
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

2.  Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding.

Authors:  Steven J Fishman; C Jason Smithers; Judah Folkman; Dennis P Lund; Patricia E Burrows; John B Mulliken; Victor L Fox
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

3.  Use of 111In platelet scans in the detection and treatment of Kasabach-Merritt syndrome.

Authors:  P M Sondel; M W Ritter; D G Wilson; L M Lieberman
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

4.  Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.

Authors:  Yasuo Ontachi; Hidesaku Asakura; Masahisa Arahata; Yasuko Kadohira; Mio Maekawa; Tomoe Hayashi; Masahide Yamazaki; Eriko Morishita; Masanori Saito; Shinji Minami; Shinji Nakao
Journal:  Circ J       Date:  2005-09       Impact factor: 2.993

5.  Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines.

Authors:  H Wada; J Thachil; M Di Nisio; P Mathew; S Kurosawa; S Gando; H K Kim; J D Nielsen; C-E Dempfle; M Levi; C-H Toh
Journal:  J Thromb Haemost       Date:  2013-02-04       Impact factor: 5.824

6.  Blue rubber bleb nevus syndrome associated with consumption coagulopathy: treatment with interferon.

Authors:  H Apak; T Celkan; A Ozkan; I Yildiz; E H Aydemir; S Ozdil; S Kuruoglu
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

Review 7.  Classifying types of disseminated intravascular coagulation: clinical and animal models.

Authors:  Hidesaku Asakura
Journal:  J Intensive Care       Date:  2014-03-06
  7 in total
  2 in total

Review 1.  Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.

Authors:  Shinya Yamada; Hidesaku Asakura
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

Review 2.  Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.

Authors:  Shinya Yamada; Hidesaku Asakura
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.